APO Research
Talk to an analyst

APO RESEARCH · REPORT

DPT Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DPT Vaccines Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchDPT Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal DPT Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global DPT Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for DPT Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DPT Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DPT Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DPT Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for DPT Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DPT Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for DPT Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DPT Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DPT Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for DPT Vaccines sales, projected growth trends, production technology, application and end-user industry.

DPT Vaccines Segment by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

DPT Vaccines Segment by Type

DTaP

Tdap

DTwP

DPT Vaccines Segment by Age

12 Months Below

12 Months Above

DPT Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of DPT Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DPT Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DPT Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DTaP Major Manufacturers Table 3. Tdap Major Manufacturers Table 4. DTwP Major Manufacturers Table 5. Global DPT Vaccines Market Size Growth Rate by Age (US$ Million), 2021 VS 2025 VS 2032 Table 6. 12 Months Below Major Manufacturers Table 7. 12 Months Above Major Manufacturers Table 8. DPT Vaccines Industry Trends Table 9. DPT Vaccines Industry Drivers Table 10. DPT Vaccines Industry Opportunities and Challenges Table 11. DPT Vaccines Industry Restraints Table 12. Global DPT Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global DPT Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global DPT Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global DPT Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global DPT Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global DPT Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 18. Global DPT Vaccines Sales by Region (2021-2026) & (M Doses) Table 19. Global DPT Vaccines Sales by Region (2027-2032) & (M Doses) Table 20. Global DPT Vaccines Sales Market Share by Region (2021-2026) Table 21. Global DPT Vaccines Sales Market Share by Region (2027-2032) Table 22. Global DPT Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global DPT Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global DPT Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global DPT Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global DPT Vaccines Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 27. Global DPT Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global DPT Vaccines Manufacturers, Product Type & Application Table 30. Global DPT Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global DPT Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global DPT Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global DPT Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global DPT Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global DPT Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 39. Global DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 40. Global DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 41. Global DPT Vaccines Sales Market Share by Type (2021-2026) Table 42. Global DPT Vaccines Sales Market Share by Type (2027-2032) Table 43. Global DPT Vaccines Price by Type (2021-2026) & (US$/Dose) Table 44. Global DPT Vaccines Price by Type (2027-2032) & (US$/Dose) Table 45. Global DPT Vaccines Revenue by Age 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 47. Global DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 48. Global DPT Vaccines Revenue Market Share by Age (2021-2026) Table 49. Global DPT Vaccines Revenue Market Share by Age (2027-2032) Table 50. Global DPT Vaccines Sales by Age 2021 VS 2025 VS 2032 (M Doses) Table 51. Global DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 52. Global DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 53. Global DPT Vaccines Sales Market Share by Age (2021-2026) Table 54. Global DPT Vaccines Sales Market Share by Age (2027-2032) Table 55. Global DPT Vaccines Price by Age (2021-2026) & (US$/Dose) Table 56. Global DPT Vaccines Price by Age (2027-2032) & (US$/Dose) Table 57. Sanofi Pasteur Company Information Table 58. Sanofi Pasteur Business Overview Table 59. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 60. Sanofi Pasteur DPT Vaccines Product Portfolio Table 61. Sanofi Pasteur Recent Development Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 65. GSK DPT Vaccines Product Portfolio Table 66. GSK Recent Development Table 67. Mitsubishi Tanabe Pharma Company Information Table 68. Mitsubishi Tanabe Pharma Business Overview Table 69. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 70. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio Table 71. Mitsubishi Tanabe Pharma Recent Development Table 72. KM Biologics Company Information Table 73. KM Biologics Business Overview Table 74. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. KM Biologics DPT Vaccines Product Portfolio Table 76. KM Biologics Recent Development Table 77. Wuhan Institute of Biological Products Company Information Table 78. Wuhan Institute of Biological Products Business Overview Table 79. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio Table 81. Wuhan Institute of Biological Products Recent Development Table 82. Walvax Biotechnology Company Information Table 83. Walvax Biotechnology Business Overview Table 84. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Walvax Biotechnology DPT Vaccines Product Portfolio Table 86. Walvax Biotechnology Recent Development Table 87. Chengdu Institute of Biological Products Company Information Table 88. Chengdu Institute of Biological Products Business Overview Table 89. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio Table 91. Chengdu Institute of Biological Products Recent Development Table 92. Minhai Biotechnology Company Information Table 93. Minhai Biotechnology Business Overview Table 94. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Minhai Biotechnology DPT Vaccines Product Portfolio Table 96. Minhai Biotechnology Recent Development Table 97. North America DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 98. North America DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 99. North America DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 100. North America DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 101. North America DPT Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 102. North America DPT Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 103. North America DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 104. North America DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 105. North America DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 106. North America DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 107. North America DPT Vaccines Sales Price by Age (2021-2026) & (US$/Dose) Table 108. North America DPT Vaccines Sales Price by Age (2027-2032) & (US$/Dose) Table 109. North America DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America DPT Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America DPT Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America DPT Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 113. North America DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 114. North America DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 115. North America DPT Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 116. North America DPT Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 117. United States DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 118. Canada DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 119. Mexico DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 120. Europe DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 123. Europe DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 124. Europe DPT Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 125. Europe DPT Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 126. Europe DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 127. Europe DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 128. Europe DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 129. Europe DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 130. Europe DPT Vaccines Sales Price by Age (2021-2026) & (US$/Dose) Table 131. Europe DPT Vaccines Sales Price by Age (2027-2032) & (US$/Dose) Table 132. Europe DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe DPT Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe DPT Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe DPT Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 136. Europe DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 137. Europe DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 138. Europe DPT Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 139. Europe DPT Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 140. Germany DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 141. France DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 142. U.K. DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 143. Italy DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 144. Russia DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 145. Spain DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 146. Netherlands DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 147. Switzerland DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 148. Sweden DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 149. Poland DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 150. China DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 151. China DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 152. China DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 153. China DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 154. China DPT Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 155. China DPT Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 156. China DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 157. China DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 158. China DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 159. China DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 160. China DPT Vaccines Sales Price by Age (2021-2026) & (US$/Dose) Table 161. China DPT Vaccines Sales Price by Age (2027-2032) & (US$/Dose) Table 162. Asia DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 165. Asia DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 166. Asia DPT Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 167. Asia DPT Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 168. Asia DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 169. Asia DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 170. Asia DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 171. Asia DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 172. Asia DPT Vaccines Sales Price by Age (2021-2026) & (US$/Dose) Table 173. Asia DPT Vaccines Sales Price by Age (2027-2032) & (US$/Dose) Table 174. Asia DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia DPT Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia DPT Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia DPT Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 178. Asia DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 179. Asia DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 180. Asia DPT Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 181. Asia DPT Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 182. Japan DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 183. South Korea DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 184. India DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Australia DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Taiwan DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 188. SAMEA DPT Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA DPT Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA DPT Vaccines Sales by Type (2021-2026) & (M Doses) Table 191. SAMEA DPT Vaccines Sales by Type (2027-2032) & (M Doses) Table 192. SAMEA DPT Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 193. SAMEA DPT Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 194. SAMEA DPT Vaccines Revenue by Age (2021-2026) & (US$ Million) Table 195. SAMEA DPT Vaccines Revenue by Age (2027-2032) & (US$ Million) Table 196. SAMEA DPT Vaccines Sales by Age (2021-2026) & (M Doses) Table 197. SAMEA DPT Vaccines Sales by Age (2027-2032) & (M Doses) Table 198. SAMEA DPT Vaccines Sales Price by Age (2021-2026) & (US$/Dose) Table 199. SAMEA DPT Vaccines Sales Price by Age (2027-2032) & (US$/Dose) Table 200. SAMEA DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA DPT Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA DPT Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA DPT Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 204. SAMEA DPT Vaccines Sales by Country (2021-2026) & (M Doses) Table 205. SAMEA DPT Vaccines Sales by Country (2027-2032) & (M Doses) Table 206. SAMEA DPT Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 207. SAMEA DPT Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 208. Brazil DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Argentina DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Chile DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Colombia DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Peru DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Israel DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 215. UAE DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Turkey DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Iran DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Egypt DPT Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. DPT Vaccines Distributors List Table 222. DPT Vaccines Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. DPT Vaccines Image Figure 2. Global DPT Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. DTaP Image Figure 5. Tdap Image Figure 6. DTwP Image Figure 7. Global DPT Vaccines Market Size Growth Rate by Age (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global DPT Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. 12 Months Below Image Figure 10. 12 Months Above Image Figure 11. Global DPT Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global DPT Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global DPT Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global DPT Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global DPT Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global DPT Vaccines Sales (2021-2032) & (M Doses) Figure 17. Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 18. Global DPT Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico DPT Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. Europe DPT Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. China DPT Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. Asia (Excluding China) DPT Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. South America, Middle East and Africa DPT Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. Global DPT Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global DPT Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global DPT Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global DPT Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global DPT Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global DPT Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 31. Global DPT Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global DPT Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global DPT Vaccines Revenue by Age (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global DPT Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global DPT Vaccines Revenue Market Share by Age (2021-2032) Figure 36. Global DPT Vaccines Sales by Age (2021 VS 2025 VS 2032) & (M Doses) Figure 37. Global DPT Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global DPT Vaccines Sales Market Share by Age (2021-2032) Figure 39. North America DPT Vaccines Revenue Share by Type (2021-2032) Figure 40. North America DPT Vaccines Sales Share by Type (2021-2032) Figure 41. North America DPT Vaccines Revenue Share by Age (2021-2032) Figure 42. North America DPT Vaccines Sales Share by Age (2021-2032) Figure 43. North America DPT Vaccines Revenue Share by Country (2021-2032) Figure 44. North America DPT Vaccines Sales Share by Country (2021-2032) Figure 45. Europe DPT Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe DPT Vaccines Sales Share by Type (2021-2032) Figure 47. Europe DPT Vaccines Revenue Share by Age (2021-2032) Figure 48. Europe DPT Vaccines Sales Share by Age (2021-2032) Figure 49. Europe DPT Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe DPT Vaccines Sales Share by Country (2021-2032) Figure 51. China DPT Vaccines Revenue Share by Type (2021-2032) Figure 52. China DPT Vaccines Sales Share by Type (2021-2032) Figure 53. China DPT Vaccines Revenue Share by Age (2021-2032) Figure 54. China DPT Vaccines Sales Share by Age (2021-2032) Figure 55. Asia DPT Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia DPT Vaccines Sales Share by Type (2021-2032) Figure 57. Asia DPT Vaccines Revenue Share by Age (2021-2032) Figure 58. Asia DPT Vaccines Sales Share by Age (2021-2032) Figure 59. Asia DPT Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia DPT Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA DPT Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA DPT Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA DPT Vaccines Revenue Share by Age (2021-2032) Figure 64. SAMEA DPT Vaccines Sales Share by Age (2021-2032) Figure 65. SAMEA DPT Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA DPT Vaccines Sales Share by Country (2021-2032) Figure 67. DPT Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. DPT Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • DTaP
  • Tdap
  • DTwP
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • KM Biologics
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Chengdu Institute of Biological Products
  • Minhai Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DPT Vaccines Market by Type
  3. 1.2.1 Global DPT Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DTaP
  5. 1.2.3 Tdap
  6. 1.2.4 DTwP
  7. 1.3 DPT Vaccines Market by Age
  8. 1.3.1 Global DPT Vaccines Market Size by Age, 2021 VS 2025 VS 2032
  9. 1.3.2 12 Months Below
  10. 1.3.3 12 Months Above
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 DPT Vaccines Market Dynamics
  1. 2.1 DPT Vaccines Industry Trends
  2. 2.2 DPT Vaccines Industry Drivers
  3. 2.3 DPT Vaccines Industry Opportunities and Challenges
  4. 2.4 DPT Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global DPT Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global DPT Vaccines Revenue by Region
  3. 3.2.1 Global DPT Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DPT Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global DPT Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global DPT Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global DPT Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global DPT Vaccines Sales by Region
  9. 3.4.1 Global DPT Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global DPT Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global DPT Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global DPT Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global DPT Vaccines Revenue by Manufacturers
  2. 4.1.1 Global DPT Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global DPT Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DPT Vaccines Sales by Manufacturers
  6. 4.2.1 Global DPT Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global DPT Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global DPT Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global DPT Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global DPT Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global DPT Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global DPT Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global DPT Vaccines Market CR5 and HHI
  16. 4.8.2 2025 DPT Vaccines Tier 1, Tier 2, and Tier 3
5 DPT Vaccines Market by Type
  1. 5.1 Global DPT Vaccines Revenue by Type
  2. 5.1.1 Global DPT Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global DPT Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global DPT Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global DPT Vaccines Sales by Type
  6. 5.2.1 Global DPT Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DPT Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global DPT Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global DPT Vaccines Price by Type
6 DPT Vaccines Market by Application
  1. 6.1 Global DPT Vaccines Revenue by Application
  2. 6.1.1 Global DPT Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global DPT Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global DPT Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global DPT Vaccines Sales by Application
  6. 6.2.1 Global DPT Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global DPT Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global DPT Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global DPT Vaccines Price by Application
7 Company Profiles
  1. 7.1 Sanofi Pasteur
  2. 7.1.1 Sanofi Pasteur Company Information
  3. 7.1.2 Sanofi Pasteur Business Overview
  4. 7.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
  6. 7.1.5 Sanofi Pasteur Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK DPT Vaccines Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Mitsubishi Tanabe Pharma
  14. 7.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 7.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 7.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
  18. 7.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 7.4 KM Biologics
  20. 7.4.1 KM Biologics Company Information
  21. 7.4.2 KM Biologics Business Overview
  22. 7.4.3 KM Biologics DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 KM Biologics DPT Vaccines Product Portfolio
  24. 7.4.5 KM Biologics Recent Developments
  25. 7.5 Wuhan Institute of Biological Products
  26. 7.5.1 Wuhan Institute of Biological Products Company Information
  27. 7.5.2 Wuhan Institute of Biological Products Business Overview
  28. 7.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
  30. 7.5.5 Wuhan Institute of Biological Products Recent Developments
  31. 7.6 Walvax Biotechnology
  32. 7.6.1 Walvax Biotechnology Company Information
  33. 7.6.2 Walvax Biotechnology Business Overview
  34. 7.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
  36. 7.6.5 Walvax Biotechnology Recent Developments
  37. 7.7 Chengdu Institute of Biological Products
  38. 7.7.1 Chengdu Institute of Biological Products Company Information
  39. 7.7.2 Chengdu Institute of Biological Products Business Overview
  40. 7.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
  42. 7.7.5 Chengdu Institute of Biological Products Recent Developments
  43. 7.8 Minhai Biotechnology
  44. 7.8.1 Minhai Biotechnology Company Information
  45. 7.8.2 Minhai Biotechnology Business Overview
  46. 7.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
  48. 7.8.5 Minhai Biotechnology Recent Developments
8 North America
  1. 8.1 North America DPT Vaccines Market Size by Type
  2. 8.1.1 North America DPT Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America DPT Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America DPT Vaccines Price by Type (2021-2032)
  5. 8.2 North America DPT Vaccines Market Size by Age
  6. 8.2.1 North America DPT Vaccines Revenue by Age (2021-2032)
  7. 8.2.2 North America DPT Vaccines Sales by Age (2021-2032)
  8. 8.2.3 North America DPT Vaccines Price by Age (2021-2032)
  9. 8.3 North America DPT Vaccines Market Size by Country
  10. 8.3.1 North America DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America DPT Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America DPT Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe DPT Vaccines Market Size by Type
  2. 9.1.1 Europe DPT Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe DPT Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe DPT Vaccines Price by Type (2021-2032)
  5. 9.2 Europe DPT Vaccines Market Size by Age
  6. 9.2.1 Europe DPT Vaccines Revenue by Age (2021-2032)
  7. 9.2.2 Europe DPT Vaccines Sales by Age (2021-2032)
  8. 9.2.3 Europe DPT Vaccines Price by Age (2021-2032)
  9. 9.3 Europe DPT Vaccines Market Size by Country
  10. 9.3.1 Europe DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe DPT Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe DPT Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China DPT Vaccines Market Size by Type
  2. 10.1.1 China DPT Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China DPT Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China DPT Vaccines Price by Type (2021-2032)
  5. 10.2 China DPT Vaccines Market Size by Age
  6. 10.2.1 China DPT Vaccines Revenue by Age (2021-2032)
  7. 10.2.2 China DPT Vaccines Sales by Age (2021-2032)
  8. 10.2.3 China DPT Vaccines Price by Age (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DPT Vaccines Market Size by Type
  2. 11.1.1 Asia DPT Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia DPT Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia DPT Vaccines Price by Type (2021-2032)
  5. 11.2 Asia DPT Vaccines Market Size by Age
  6. 11.2.1 Asia DPT Vaccines Revenue by Age (2021-2032)
  7. 11.2.2 Asia DPT Vaccines Sales by Age (2021-2032)
  8. 11.2.3 Asia DPT Vaccines Price by Age (2021-2032)
  9. 11.3 Asia DPT Vaccines Market Size by Country
  10. 11.3.1 Asia DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia DPT Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia DPT Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DPT Vaccines Market Size by Type
  2. 12.1.1 SAMEA DPT Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA DPT Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA DPT Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA DPT Vaccines Market Size by Age
  6. 12.2.1 SAMEA DPT Vaccines Revenue by Age (2021-2032)
  7. 12.2.2 SAMEA DPT Vaccines Sales by Age (2021-2032)
  8. 12.2.3 SAMEA DPT Vaccines Price by Age (2021-2032)
  9. 12.3 SAMEA DPT Vaccines Market Size by Country
  10. 12.3.1 SAMEA DPT Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA DPT Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA DPT Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 DPT Vaccines Value Chain Analysis
  2. 13.1.1 DPT Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 DPT Vaccines Production Mode & Process
  6. 13.2 DPT Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 DPT Vaccines Distributors
  9. 13.2.3 DPT Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst